Clinical characteristics of central compartment atopic disease in Southern China

医学 过敏性 鼻息肉 入射(几何) 过敏 哮喘 鼻窦炎 内科学 慢性鼻-鼻窦炎 嗜酸性 胃肠病学 免疫学 病理 光学 物理
作者
Zhiying Nie,Zhaofeng Xu,Yunping Fan,Yuanyuan Guo,Chuxin Chen,Wendong Liu,Yueqi Li,Yinyan Lai,Jianbo Shi,Fenghong Chen
出处
期刊:International Forum of Allergy & Rhinology [Wiley]
卷期号:13 (3): 205-215 被引量:8
标识
DOI:10.1002/alr.23069
摘要

Central compartment atopic disease (CCAD) is a newly reported subset of chronic rhinosinusitis. It was considered associated with inhalant antigen. However, CCAD in Chinese population is not fully studied yet.Prospective cohort study.This study aimed to describe the clinical manifestations of CCAD and compared the following two subtypes: sinonasal polyps and concomitant polypoid disease in the central compartment (CRSwNP/CC) and CRSwNP not otherwise specified (CRSwNP NOS). Also, we compared the clinical manifestations of atopy CCAD and non-atopy CCAD.We consecutively enrolled CRSwNP patients without prior sinus surgery, and assessed the nasal endoscopy and computed tomography of the paranasal sinuses. Allergy was confirmed by skin or serum testing. Eosinophilic CRSwNP (ECRS) was considered as tissue eosinophils to total inflammatory cells >10%.We enrolled a total of 116 patients, including 39 with CCAD, 38 with CRSwNP/CC and 39 with CRSwNP NOS. Atopy was detected in 37.1% of the CCAD group, an incidence showing no significant difference from those in the other two groups (37.1% in the CRSwNP/CC group, 31.0% in the CRSwNP NOS group; p = 0.846). However, the incidence of ECRS in the CCAD group was the highest among the different groups (97.4% in the CCAD group vs. 67.6% in the CRSwNP/CC group vs. 35.1% in the CRSwNP NOS group; p = 0.000). In addition, the incidence of asthma in the CCAD group (33.3%) was significantly higher than that in the CRSwNP NOS group (10.3%), but quite similar to CRSwNP/CC (34.2%). In the subgroup analysis of CCAD, only total serum IgE and sIgE demonstrated significant differences between atopy CCAD and non-atopy CCAD.CCAD in Southern China may associate with asthma and significant eosinophilia, with a lower incidence of systemic allergy based on skin and serum testing.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lily336699应助j736999565采纳,获得10
刚刚
寻找土豆的灯完成签到 ,获得积分10
刚刚
丰知然应助科研通管家采纳,获得30
1秒前
科目三应助科研通管家采纳,获得10
1秒前
丰知然应助科研通管家采纳,获得10
1秒前
深情安青应助科研通管家采纳,获得10
1秒前
wanci应助科研通管家采纳,获得10
1秒前
爆米花应助科研通管家采纳,获得10
1秒前
完美世界应助科研通管家采纳,获得10
1秒前
无花果应助科研通管家采纳,获得10
1秒前
漂泊1991完成签到,获得积分10
1秒前
在水一方应助科研通管家采纳,获得200
1秒前
云瑾应助科研通管家采纳,获得10
1秒前
灿烂千阳发布了新的文献求助10
1秒前
爆米花应助科研通管家采纳,获得30
1秒前
云瑾应助科研通管家采纳,获得10
1秒前
2秒前
感动清炎完成签到,获得积分10
2秒前
2秒前
仇湘完成签到,获得积分10
2秒前
丹丹发布了新的文献求助10
2秒前
3秒前
yeyeye发布了新的文献求助10
3秒前
小璐璐呀完成签到,获得积分10
3秒前
ECT完成签到,获得积分10
4秒前
4秒前
失眠迎蕾完成签到,获得积分10
4秒前
wanci应助4712采纳,获得10
4秒前
4秒前
快乐梦安完成签到,获得积分20
5秒前
5秒前
5秒前
雪掩的往事完成签到,获得积分10
5秒前
仇道罡完成签到,获得积分10
6秒前
Army616发布了新的文献求助10
6秒前
坤子关注了科研通微信公众号
7秒前
所所应助ZengQiu采纳,获得10
7秒前
尹冰露发布了新的文献求助10
7秒前
7秒前
8秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
Dynamic Craniotomy With Khanna NuCrani Plates as an Alternative to Craniotomy With Fixed Plates in Traumatic Brain Injury 1000
Impiego dell’associazione acetazolamide/pentossifillina nel trattamento dell’ipoacusia improvvisa idiopatica in pazienti affetti da glaucoma cronico 900
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
錢鍾書楊絳親友書札 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3294979
求助须知:如何正确求助?哪些是违规求助? 2931033
关于积分的说明 8449725
捐赠科研通 2603561
什么是DOI,文献DOI怎么找? 1421144
科研通“疑难数据库(出版商)”最低求助积分说明 660825
邀请新用户注册赠送积分活动 643654